申请人:Kali-Chemie Pharma GmbH
公开号:US04497740A1
公开(公告)日:1985-02-05
New 2-acylaminomethyl-1H-2,3-dihydro-1,4-benzodiazepine compounds are described having the general formula I ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl or alkenyl radical or the cyclopropylmethyl radical, R.sub.2 is a hydrogen atom, or a lower alkyl or alkenyl radical, n is 0, 1 or 2, R.sub.3 is an optionally substituted furyl, thienyl, pyrrolyl, pyridyl or phenyl radical, R.sub.4 is an optionally substituted furyl, thienyl, pyrrolyl or pyridyl radical, R.sub.5 is a hydrogen or halogen atom, or a lower alkyl, lower alkoxy, hydroxyl, lower alkylthio, nitro, trifluoromethyl, cyano, amino, lower mono- or dialkylamino, lower monoalkanoylamino, lower N-alkyl-N-alkanoylamino or lower alkanoyloxy radical, and R.sub.6 is a hydrogen atom, or a lower alkyl or lower alkoxy radical or R.sub.5 and R.sub.6 together denote a methylenedioxy or ethylenedioxy radical. The compounds have pharmacological, for example, analgesic, properties.
描述了具有一般式I的新2-酰胺甲基-1H-2,3-二氢-1,4-苯二氮䓬化合物,其中R.sub.1是氢原子或较低的烷基或烯基基团或环丙甲基基团,R.sub.2是氢原子,或较低的烷基或烯基基团,n为0、1或2,R.sub.3是一个可选择地取代的呋喃基、噻吩基、吡咯基、吡啶基或苯基,R.sub.4是一个可选择地取代的呋喃基、噻吩基、吡咯基或吡啶基,R.sub.5是氢原子或卤素原子,或较低的烷基、较低的烷氧基、羟基、较低的烷硫基、硝基、三氟甲基、氰基、氨基、较低的单烷基或二烷基氨基、较低的单烷酰氨基、较低的N-烷基-N-烷酰氨基或较低的烷酰氧基基团,R.sub.6是氢原子,或较低的烷基或较低的烷氧基基团,或R.sub.5和R.sub.6一起表示亚甲二氧基或乙烯二氧基基团。这些化合物具有药理学特性,例如镇痛特性。